Fungal keratitis, one of the major causes of ophthalmic mycosis is second only to cataract as the most common cause of blindness worldwide.
OBJECTIVEThe aim was to study the intracorneal and intracameral Voriconazole in deep keratomycosis with endothelial plaque.
MATERIALS AND METHODSThis was a study in the Cornea Clinic of Sarojini Devi Eye Hospital and Regional Institute of Ophthalmology, a Tertiary Care Teaching Hospital of Osmania Medical College (Govt.), Hyderabad, over a period from September 2012 to August 2014. The study group included 30 patients who were diagnosed clinically and microbiologically (+ve smear and culture) as fungal corneal ulcers with deep stromal infiltrates and endothelial plaque not responding to routine antifungal drugs and given voriconazole intracorneally and intracamerally.Data of patient's age and sex and history of corneal trauma with type of the agents were noted. The time of healing of the ulcer with the scar formation after intracorneal and intracameral voriconazole was noted and the visual acuity was recorded after the healing of the corneal ulcer.
RESULTSThirty eyes of 30 patients with deep keratomycosis with endothelial plaque were evaluated; 19(63.3%) were Males and 11(36.7%) were Females. ; 12 (40.0%) in 6-8 wks., 5(16.7%) in 8-10 wks., and 4(13.3%) in 10-12 wks.; 25(83.3%) which were healed by corneal scarring were given 1 (One) intracorneal and intracameral injection of Voriconazole. The 5(16.7%) did not respond to 2 (Two) intracorneal and intracameral voriconazole injections, progressed to corneal perforations and were treated by Therapeutic Penetrating keratoplasty. Visual acuity was <3/60 in 18(60.0%) and 3/60 to <6/60 in 12(40.0%), and <3/60 in 3(10.0%), 3/60-<6/60 in 13(43.3%) and 6/60-<6/18 in 9(30.0%) before and after the intracorneal and intracameral voriconazole respectively.
CONCLUSIONSTargeted delivery of Intracorneal and Intracameral Voriconazole was effective with a better visual outcome and a significant reduction in healing time in deep keratomycosis with endothelial plaque not responding to routine antifungal therapy.